Diazepam

地西泮

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameDiazepam
Drug Alias Namediazepamum苯甲二氮䓬diazepam二氮平Diazepam - Aquestive Therapeutics +[25] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxiety DisordersAnxietyStatus Epilepticus +[14] 
Global Approved IndicationsAnxiety DisordersAlcohol Withdrawal SeizuresSpasm +[5] 
Approved Indications in ChinaEpilepsy
Original Approved Country/TerritoryUnited States
Original Approved Date1963/11/15
Country/TerritoryUnited StatesBrazilMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeuraxpharmAculys Pharma LLCUniversity Of Monastir +[7] 
Inactive CompaniesAcorda TherapeuticsOffice Of Us Army Medical Research And Material CommandUniversity of Brasilia +[6] 
Active IndicationsAnxiety DisordersAlcohol Withdrawal SeizuresSpasm +[6] 
Inactive IndicationsAnxietyStatus EpilepticusSeizures +[8] 

Other Information

ATC CodeN05BA01
Related LinksWikipediaDrugBankKEGG